Growth Metrics

Merck (MRK) Return on Sales (2016 - 2025)

Merck (MRK) has disclosed Return on Sales for 17 consecutive years, with 0.18% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 6.0% to 0.18% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.28% through Dec 2025, up 1.0% year-over-year, with the annual reading at 0.28% for FY2025, 1.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.18% at Merck, down from 0.33% in the prior quarter.
  • The five-year high for Return on Sales was 0.34% in Q2 2024, with the low at 0.4% in Q2 2023.
  • Average Return on Sales over 5 years is 0.12%, with a median of 0.18% recorded in 2025.
  • The sharpest move saw Return on Sales crashed -40bps in 2023, then surged 74bps in 2024.
  • Over 5 years, Return on Sales stood at 0.0% in 2021, then surged by 77bps to 0.0% in 2022, then crashed by -7871bps to 0.08% in 2023, then soared by 386bps to 0.24% in 2024, then decreased by -25bps to 0.18% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.18%, 0.33%, and 0.28% for Q4 2025, Q3 2025, and Q2 2025 respectively.